XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating Activities    
Net Income Including the Noncontrolling Interests in Subsidiaries $ 105,355 $ 127,825
Adjustments to Reconcile Net Income to Net Cash Provided (Used) by Operating Activities    
Depreciation and Amortization 14,423 14,999
Share-Based Compensation Expense 18,720 16,976
Subsidiary Share-Based Compensation Expense 707 4,999
(Gain) Loss on Disposal of Assets (737) (5,163)
Provision (Benefit) for Deferred Income Taxes (2,163) 18,678
Consolidation/(Deconsolidation) of Other Entities (20) 11,029
Net Unrealized (Gain) Loss on Investments 33,315 (2,442)
Net Sales (Purchases) of Investments—Consolidated Investment Companies (43,219) (64,399)
Other Changes in Assets and Liabilities:    
(Increase) Decrease in Receivables, net 10 6,933
(Increase) Decrease in Prepaid Expenses and Other Assets (3,526) (2,504)
Increase (Decrease) in Accounts Payable and Accrued Expenses (53,008) (67,723)
Increase (Decrease) in Other Liabilities 9,659 (4,257)
Net Cash Provided (Used) by Operating Activities 79,516 54,951
Investing Activities    
Purchases of Investments—Affiliates and Other (5,081) (5,643)
Proceeds from Redemptions of Investments—Affiliates and Other 8,067 13,915
Cash Paid for Property and Equipment (2,889) (3,255)
Net Cash Provided (Used) by Investing Activities 97 5,017
Financing Activities    
Dividends Paid (49,659) (53,339)
Purchases of Treasury Stock (204,604) (77,973)
Distributions to Noncontrolling Interests in Subsidiaries (5,524) (2,914)
Contributions from Noncontrolling Interests in Subsidiaries 45,654 34,394
Proceeds from New Borrowings 488,300 0
Payments on Debt (311,650) (10,000)
Other Financing Activities (9,484) (1,978)
Net Cash Provided (Used) by Financing Activities (46,967) (111,810)
Effect of Exchange Rates on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (17,717) 1,826
Net Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14,929 (50,016)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning of Period 238,052 308,635
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, End of Period 252,981 258,619
Less: Restricted Cash Recorded in Other Current Assets 3,978 4,598
Less: Restricted Cash and Restricted Cash Equivalents Recorded in Other Long-Term Assets 271 289
Cash and Cash Equivalents $ 248,732 $ 253,732